A citation-based method for searching scientific literature

Alexander Roesch, Adina Vultur, Ivan Bogeski, Huan Wang, Katharina M Zimmermann, David Speicher, Christina Körbel, Matthias W Laschke, Phyllis A Gimotty, Stephan E Philipp, Elmar Krause, Sylvie Pätzold, Jessie Villanueva, Clemens Krepler, Mizuho Fukunaga-Kalabis, Markus Hoth, Boris C Bastian, Thomas Vogt, Meenhard Herlyn. Cancer Cell 2013
Times Cited: 446







List of co-cited articles
1218 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations.
Sreenath V Sharma, Diana Y Lee, Bihua Li, Margaret P Quinlan, Fumiyuki Takahashi, Shyamala Maheswaran, Ultan McDermott, Nancy Azizian, Lee Zou, Michael A Fischbach,[...]. Cell 2010
34

A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth.
Alexander Roesch, Mizuho Fukunaga-Kalabis, Elizabeth C Schmidt, Susan E Zabierowski, Patricia A Brafford, Adina Vultur, Devraj Basu, Phyllis Gimotty, Thomas Vogt, Meenhard Herlyn. Cell 2010
827
33

Toward Minimal Residual Disease-Directed Therapy in Melanoma.
Florian Rambow, Aljosja Rogiers, Oskar Marin-Bejar, Sara Aibar, Julia Femel, Michael Dewaele, Panagiotis Karras, Daniel Brown, Young Hwan Chang, Maria Debiec-Rychter,[...]. Cell 2018
276
24

Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function.
Andrea Viale, Piergiorgio Pettazzoni, Costas A Lyssiotis, Haoqiang Ying, Nora Sánchez, Matteo Marchesini, Alessandro Carugo, Tessa Green, Sahil Seth, Virginia Giuliani,[...]. Nature 2014
755
21

Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance.
Sydney M Shaffer, Margaret C Dunagin, Stefan R Torborg, Eduardo A Torre, Benjamin Emert, Clemens Krepler, Marilda Beqiri, Katrin Sproesser, Patricia A Brafford, Min Xiao,[...]. Nature 2017
517
20

Oncogenic BRAF regulates oxidative metabolism via PGC1α and MITF.
Rizwan Haq, Jonathan Shoag, Pedro Andreu-Perez, Satoru Yokoyama, Hannah Edelman, Glenn C Rowe, Dennie T Frederick, Aeron D Hurley, Abhinav Nellore, Andrew L Kung,[...]. Cancer Cell 2013
568
18

Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq.
Itay Tirosh, Benjamin Izar, Sanjay M Prakadan, Marc H Wadsworth, Daniel Treacy, John J Trombetta, Asaf Rotem, Christopher Rodman, Christine Lian, George Murphy,[...]. Science 2016
16

Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma.
Judith Müller, Oscar Krijgsman, Jennifer Tsoi, Lidia Robert, Willy Hugo, Chunying Song, Xiangju Kong, Patricia A Possik, Paulien D M Cornelissen-Steijger, Marnix H Geukes Foppen,[...]. Nat Commun 2014
379
15

PGC1α expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress.
Francisca Vazquez, Ji-Hong Lim, Helen Chim, Kavita Bhalla, Geoff Girnun, Kerry Pierce, Clary B Clish, Scott R Granter, Hans R Widlund, Bruce M Spiegelman,[...]. Cancer Cell 2013
492
15

Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition.
Aaron N Hata, Matthew J Niederst, Hannah L Archibald, Maria Gomez-Caraballo, Faria M Siddiqui, Hillary E Mulvey, Yosef E Maruvka, Fei Ji, Hyo-eun C Bhang, Viveksagar Krishnamurthy Radhakrishna,[...]. Nat Med 2016
540
14

Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition.
Matthew J Hangauer, Vasanthi S Viswanathan, Matthew J Ryan, Dhruv Bole, John K Eaton, Alexandre Matov, Jacqueline Galeas, Harshil D Dhruv, Michael E Berens, Stuart L Schreiber,[...]. Nature 2017
573
13

Melanoma plasticity and phenotypic diversity: therapeutic barriers and opportunities.
Florian Rambow, Jean-Christophe Marine, Colin R Goding. Genes Dev 2019
111
12

An inhibitor of oxidative phosphorylation exploits cancer vulnerability.
Jennifer R Molina, Yuting Sun, Marina Protopopova, Sonal Gera, Madhavi Bandi, Christopher Bristow, Timothy McAfoos, Pietro Morlacchi, Jeffrey Ackroyd, Ahmed-Noor A Agip,[...]. Nat Med 2018
379
12

Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug Tolerance.
Brian B Liau, Cem Sievers, Laura K Donohue, Shawn M Gillespie, William A Flavahan, Tyler E Miller, Andrew S Venteicher, Christine H Hebert, Christopher D Carey, Scott J Rodig,[...]. Cell Stem Cell 2017
242
12

Diverse drug-resistance mechanisms can emerge from drug-tolerant cancer persister cells.
Michael Ramirez, Satwik Rajaram, Robert J Steininger, Daria Osipchuk, Maike A Roth, Leanna S Morinishi, Louise Evans, Weiyue Ji, Chien-Hsiang Hsu, Kevin Thurley,[...]. Nat Commun 2016
285
12

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
12

An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cells.
Maia Vinogradova, Victor S Gehling, Amy Gustafson, Shilpi Arora, Charles A Tindell, Catherine Wilson, Kaylyn E Williamson, Gulfem D Guler, Pranoti Gangurde, Wanda Manieri,[...]. Nat Chem Biol 2016
186
12

Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress.
Jennifer Tsoi, Lidia Robert, Kim Paraiso, Carlos Galvan, Katherine M Sheu, Johnson Lay, Deborah J L Wong, Mohammad Atefi, Roksana Shirazi, Xiaoyan Wang,[...]. Cancer Cell 2018
320
11

Non-genomic and Immune Evolution of Melanoma Acquiring MAPKi Resistance.
Willy Hugo, Hubing Shi, Lu Sun, Marco Piva, Chunying Song, Xiangju Kong, Gatien Moriceau, Aayoung Hong, Kimberly B Dahlman, Douglas B Johnson,[...]. Cell 2015
386
10

JARID1B is a luminal lineage-driving oncogene in breast cancer.
Shoji Yamamoto, Zhenhua Wu, Hege G Russnes, Shinji Takagi, Guillermo Peluffo, Charles Vaske, Xi Zhao, Hans Kristian Moen Vollan, Reo Maruyama, Muhammad B Ekram,[...]. Cancer Cell 2014
124
10

KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic Resistance.
Kunihiko Hinohara, Hua-Jun Wu, Sébastien Vigneau, Thomas O McDonald, Kyomi J Igarashi, Kimiyo N Yamamoto, Thomas Madsen, Anne Fassl, Shawn B Egri, Malvina Papanastasiou,[...]. Cancer Cell 2018
99
10

Single-cell analysis resolves the cell state transition and signaling dynamics associated with melanoma drug-induced resistance.
Yapeng Su, Wei Wei, Lidia Robert, Min Xue, Jennifer Tsoi, Angel Garcia-Diaz, Blanca Homet Moreno, Jungwoo Kim, Rachel H Ng, Jihoon W Lee,[...]. Proc Natl Acad Sci U S A 2017
117
10

A restricted cell population propagates glioblastoma growth after chemotherapy.
Jian Chen, Yanjiao Li, Tzong-Shiue Yu, Renée M McKay, Dennis K Burns, Steven G Kernie, Luis F Parada. Nature 2012
10

A stress-induced early innate response causes multidrug tolerance in melanoma.
D Ravindran Menon, S Das, C Krepler, A Vultur, B Rinner, S Schauer, K Kashofer, K Wagner, G Zhang, E Bonyadi Rad,[...]. Oncogene 2015
78
12

Colorectal Cancer Cells Enter a Diapause-like DTP State to Survive Chemotherapy.
Sumaiyah K Rehman, Jennifer Haynes, Evelyne Collignon, Kevin R Brown, Yadong Wang, Allison M L Nixon, Jeffrey P Bruce, Jeffrey A Wintersinger, Arvind Singh Mer, Edwyn B L Lo,[...]. Cell 2021
96
10

EMT, CSCs, and drug resistance: the mechanistic link and clinical implications.
Tsukasa Shibue, Robert A Weinberg. Nat Rev Clin Oncol 2017
10

A melanoma cell state distinction influences sensitivity to MAPK pathway inhibitors.
David J Konieczkowski, Cory M Johannessen, Omar Abudayyeh, Jong Wook Kim, Zachary A Cooper, Adriano Piris, Dennie T Frederick, Michal Barzily-Rokni, Ravid Straussman, Rizwan Haq,[...]. Cancer Discov 2014
338
9

Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway.
Vasanthi S Viswanathan, Matthew J Ryan, Harshil D Dhruv, Shubhroz Gill, Ossia M Eichhoff, Brinton Seashore-Ludlow, Samuel D Kaffenberger, John K Eaton, Kenichi Shimada, Andrew J Aguirre,[...]. Nature 2017
669
9

Persistent Cancer Cells: The Deadly Survivors.
Shensi Shen, Stéphan Vagner, Caroline Robert. Cell 2020
59
15

Understanding the Warburg effect: the metabolic requirements of cell proliferation.
Matthew G Vander Heiden, Lewis C Cantley, Craig B Thompson. Science 2009
9

Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis.
William W Wheaton, Samuel E Weinberg, Robert B Hamanaka, Saul Soberanes, Lucas B Sullivan, Elena Anso, Andrea Glasauer, Eric Dufour, Gokhan M Mutlu, Gr Scott Budigner,[...]. Elife 2014
663
9

Non-genetic mechanisms of therapeutic resistance in cancer.
Jean-Christophe Marine, Sarah-Jane Dawson, Mark A Dawson. Nat Rev Cancer 2020
138
9

A landscape of driver mutations in melanoma.
Eran Hodis, Ian R Watson, Gregory V Kryukov, Stefan T Arold, Marcin Imielinski, Jean-Philippe Theurillat, Elizabeth Nickerson, Daniel Auclair, Liren Li, Chelsea Place,[...]. Cell 2012
8

In vivo switching of human melanoma cells between proliferative and invasive states.
Keith S Hoek, Ossia M Eichhoff, Natalie C Schlegel, Udo Döbbeling, Nikita Kobert, Leo Schaerer, Silvio Hemmi, Reinhard Dummer. Cancer Res 2008
471
8


Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature.
Keith S Hoek, Natalie C Schlegel, Patricia Brafford, Antje Sucker, Selma Ugurel, Rajiv Kumar, Barbara L Weber, Katherine L Nathanson, David J Phillips, Meenhard Herlyn,[...]. Pigment Cell Res 2006
373
8

Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation.
Ramin Nazarian, Hubing Shi, Qi Wang, Xiangju Kong, Richard C Koya, Hane Lee, Zugen Chen, Mi-Kyung Lee, Narsis Attar, Hooman Sazegar,[...]. Nature 2010
8

JARID1B Enables Transit between Distinct States of the Stem-like Cell Population in Oral Cancers.
Nicole D Facompre, Kayla M Harmeyer, Xavier Sole, Sheheryar Kabraji, Zachary Belden, Varun Sahu, Kelly Whelan, Koji Tanaka, Gregory S Weinstein, Kathleen T Montone,[...]. Cancer Res 2016
38
21

The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset.
Craig J Ceol, Yariv Houvras, Judit Jane-Valbuena, Steve Bilodeau, David A Orlando, Valentine Battisti, Lauriane Fritsch, William M Lin, Travis J Hollmann, Fabrizio Ferré,[...]. Nature 2011
371
8

The great escape: tumour cell plasticity in resistance to targeted therapy.
Soufiane Boumahdi, Frederic J de Sauvage. Nat Rev Drug Discov 2020
208
8

Repression of Stress-Induced LINE-1 Expression Protects Cancer Cell Subpopulations from Lethal Drug Exposure.
Gulfem Dilek Guler, Charles Albert Tindell, Robert Pitti, Catherine Wilson, Katrina Nichols, Tommy KaiWai Cheung, Hyo-Jin Kim, Matthew Wongchenko, Yibing Yan, Benjamin Haley,[...]. Cancer Cell 2017
107
8

The cancer stem cell marker aldehyde dehydrogenase is required to maintain a drug-tolerant tumor cell subpopulation.
Debasish Raha, Timothy R Wilson, Jing Peng, David Peterson, Peng Yue, Marie Evangelista, Catherine Wilson, Mark Merchant, Jeff Settleman. Cancer Res 2014
173
8

Intravital imaging reveals how BRAF inhibition generates drug-tolerant microenvironments with high integrin β1/FAK signaling.
Eishu Hirata, Maria Romina Girotti, Amaya Viros, Steven Hooper, Bradley Spencer-Dene, Michiyuki Matsuda, James Larkin, Richard Marais, Erik Sahai. Cancer Cell 2015
357
8

Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance.
Meghna Das Thakur, Fernando Salangsang, Allison S Landman, William R Sellers, Nancy K Pryer, Mitchell P Levesque, Reinhard Dummer, Martin McMahon, Darrin D Stuart. Nature 2013
525
8

Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitors.
Gao Zhang, Dennie T Frederick, Lawrence Wu, Zhi Wei, Clemens Krepler, Satish Srinivasan, Young Chan Chae, Xiaowei Xu, Harry Choi, Elaida Dimwamwa,[...]. J Clin Invest 2016
175
8

MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative Phosphorylation.
Kyung-Min Lee, Jennifer M Giltnane, Justin M Balko, Luis J Schwarz, Angel L Guerrero-Zotano, Katherine E Hutchinson, Mellissa J Nixon, Mónica V Estrada, Violeta Sánchez, Melinda E Sanders,[...]. Cell Metab 2017
272
8

Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism.
Thomas Farge, Estelle Saland, Fabienne de Toni, Nesrine Aroua, Mohsen Hosseini, Robin Perry, Claudie Bosc, Mayumi Sugita, Lucille Stuani, Marine Fraisse,[...]. Cancer Discov 2017
371
8

Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma.
Chong Sun, Liqin Wang, Sidong Huang, Guus J J E Heynen, Anirudh Prahallad, Caroline Robert, John Haanen, Christian Blank, Jelle Wesseling, Stefan M Willems,[...]. Nature 2014
544
8

KDM5B Promotes Drug Resistance by Regulating Melanoma-Propagating Cell Subpopulations.
Xiaoni Liu, Shang-Min Zhang, Meaghan K McGeary, Irina Krykbaeva, Ling Lai, Daniel J Jansen, Stephen C Kales, Anton Simeonov, Matthew D Hall, Daniel P Kelly,[...]. Mol Cancer Ther 2019
24
33

Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF/MEK inhibitors.
Julia Boshuizen, Louise A Koopman, Oscar Krijgsman, Aida Shahrabi, Elke Gresnigt- van den Heuvel, Maarten A Ligtenberg, David W Vredevoogd, Kristel Kemper, Thomas Kuilman, Ji-Ying Song,[...]. Nat Med 2018
123
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.